Drugs Made In America Acquisition Ownership | Who Owns Drugs Made In America Acquisition?
Drugs Made In America Acquisition Ownership Summary
Drugs Made In America Acquisition is owned by 10.06% institutional investors, 26.77% insiders, and 63.17% retail investors. Karpus management is the largest institutional shareholder, holding 7.60% of DMAA shares.
DMAA Ownership Benchmark
| Type | Name | % Inst | % Insiders | % Retail |
|---|---|---|---|---|
| Stock | Drugs Made In America Acquisition | 10.06% | 26.77% | 63.17% |
| Industry | Shell Companies Stocks | 235.09% | 18.98% | -154.07% |
Institutional Shareholders
Top Institutional Shareholders by Total Shares
| Holder | Shares | % Holding | Value |
|---|---|---|---|
| Karpus management | 2.55M | 7.60% | $26.16M |
| Polar asset management partners | 1.90M | 5.67% | $19.51M |
| Glazer capital | 1.82M | 5.44% | $18.71M |
| Westchester capital management | 1.67M | 4.98% | $17.14M |
| Hudson bay capital management lp | 1.55M | 4.62% | $15.92M |
| Wolverine asset management | 1.25M | 3.73% | $12.83M |
| Mizuho securities usa | 1.10M | 3.28% | $11.29M |
| Aristeia capital | 881.72K | 2.63% | $9.06M |
| Heights capital management | 650.00K | 1.94% | $6.68M |
| Radcliffe capital management | 528.10K | 1.58% | $5.42M |
Top Institutional Shareholders by % of Total Assets
| Holder | Shares | % Assets | Value |
|---|---|---|---|
| Atw spac management | 500.00K | 6.48% | $5.13B |
| Heights capital management | 650.00K | 1.83% | $6.68M |
| Karpus management | 2.55M | 0.83% | $26.16M |
| Westchester capital management | 1.67M | 0.78% | $17.14M |
| Glazer capital | 1.82M | 0.63% | $18.71M |
| Sandia investment management lp | 15.72K | 0.48% | $161.46K |
| Radcliffe capital management | 528.10K | 0.34% | $5.42M |
| Bulldog investors, llp | 130.26K | 0.31% | $1.34M |
| Mizuho securities usa | 1.10M | 0.23% | $11.29M |
| Polar asset management partners | 1.90M | 0.22% | $19.51M |
Top Buyers
| Holder | Shares | % Assets | Change |
|---|---|---|---|
| J. goldman & co lp | 500.00K | 0.13% | 500.00K |
| Radcliffe capital management | 528.10K | 0.34% | 401.38K |
| Rivernorth capital management | 318.00K | 0.19% | 318.00K |
| Context capital management | 250.00K | 0.08% | 250.00K |
| Wolverine asset management | 1.25M | 0.09% | 227.22K |
Top Sellers
| Holder | Shares | % Assets | Change |
|---|---|---|---|
| Mangrove partners | - | - | -350.00K |
| Hudson bay capital management lp | 1.55M | 0.05% | -250.00K |
| Karpus management | 2.55M | 0.83% | -196.44K |
| Schonfeld strategic advisors | - | - | -149.22K |
| Verition fund management | - | - | -100.00K |
New Positions
| Holder | Shares | % Assets | Change | Value |
|---|---|---|---|---|
| J. goldman & co lp | 500.00K | 0.13% | 500.00K | $5.13M |
| Rivernorth capital management | 318.00K | 0.19% | 318.00K | $3.27M |
| Context capital management | 250.00K | 0.08% | 250.00K | $2.57B |
| Clear street group | 209.57K | 0.01% | 209.57K | $2.15M |
| Jpmorgan chase | 99.69K | 0.00% | 99.69K | $1.02M |
Sold Out
| Holder | Change |
|---|---|
| Virtu financial | -46.69K |
| Logan stone capital | -60.99K |
| Verition fund management | -100.00K |
| Schonfeld strategic advisors | -149.22K |
| Mangrove partners | -350.00K |
Institutional Ownership Trends
| Date | Holdings | Change % | Shares | Change % | Ownership | Change % | Increased Position | Change % | Decreased Position | Change % |
|---|---|---|---|---|---|---|---|---|---|---|
| Sep 30, 2025 | 8 | -75.00% | 3,373,368 | -83.80% | 10 | 0.26% | 5 | -72.22% | 1 | -83.33% |
| Jun 30, 2025 | 32 | 33.33% | 20,823,195 | 10.54% | 216,620 | 0.00% | 18 | -21.74% | 6 | - |
| Mar 31, 2025 | 25 | - | 19,688,102 | - | 229,706 | - | 24 | - | - | - |
Recent Insider Transactions
| Date | Name | Role | Activity | Value |
|---|---|---|---|---|
| Feb 18, 2025 | Drugs Made In America Acquisition LLC | - | Buy | - |
| Feb 18, 2025 | Drugs Made In America Acquisition LLC | - | Buy | - |
| Feb 18, 2025 | Stockwell Lynn | CEO and Exe. Chair of Board | Buy | - |
| Feb 18, 2025 | Stockwell Lynn | CEO and Exe. Chair of Board | Buy | - |
| Jan 29, 2025 | Drugs Made In America Acquisition LLC | - | Buy | - |
Insider Transactions Trends
| Date | Buy | Sell |
|---|---|---|
| 2025 Q1 | 8 | 2 |
DMAA Ownership FAQ
Try Tickergate Pro Free
Customize Everything. 100% Flexibility. Fast and Easy to Use (No code or Excel Needed)
Customize your own personal stocks lists, views and charts
Choose from hundreds of fields, up to 15 years of history
Conduct deep comparison analysis
Discover trending investment themes
Find your next best investment
Research stocks using tools